Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1201 - 1300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1201 | 26798368 |
US |
85 | 1 |
Skin disorder, Rash, Hypersomnia, Dermatitis atopic, Drug hypersensitivity, |
||||
EMPAGLIFLOZIN, DUPILUMAB, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, MELATONIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, ERGOCALCIFEROL, SERTRALINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1202 | 26798488 |
US |
2 | |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, |
||||
| 1203 | 26798501 |
US |
30 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1204 | 26798510 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1205 | 26798700 |
US |
13 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1206 | 26798702 |
US |
34 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, NALTREXONE, |
||||
| 1207 | 26798707 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1208 | 26798709 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1209 | 26798714 |
US |
32 | 2 |
Dermatitis atopic, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1210 | 26798898 |
US |
||
Dermatitis atopic, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1211 | 26798918 |
US |
25 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1212 | 26799137 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1213 | 26799141 |
US |
1 | |
Eczema, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, AMLODIPINE BESYLATE, ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, TESTOSTERONE CYPIONATE, TRETINOIN, DULAGLUTIDE, ERGOCALCIFEROL, |
||||
| 1214 | 26799168 |
US |
20 | 2 |
Migraine, Skin infection, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1215 | 26799391 |
US |
57 | 2 |
Oral herpes, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1216 | 26799671 |
US |
41 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1217 | 26799694 |
US |
3 | 2 |
Varicella, Dermatitis atopic, |
||||
DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 1218 | 26800027 |
US |
36 | 1 |
Vision blurred, Myalgia, Arthralgia, Dermatitis atopic, Dry eye, |
||||
DUPILUMAB, |
||||
| 1219 | 26800394 |
US |
78 | 1 |
Rash, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1220 | 26800408 |
US |
63 | 1 |
Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 1221 | 26800431 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1222 | 26800814 |
US |
17 | 2 |
Pruritus, Dermatitis atopic, Erythema, Skin exfoliation, Stress, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1223 | 26801006 |
BR |
14 | 2 |
Fistula, Therapeutic product effect incomplete, Dermatitis atopic, Autism spectrum disorder, Chronic spontaneous urticaria, |
||||
ADALIMUMAB, |
||||
| 1224 | 26801163 |
US |
||
Pain, Pruritus, Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1225 | 26801241 |
US |
85 | 1 |
Dermatitis atopic, Rash macular, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1226 | 26801269 |
US |
23 | 1 |
Dermatitis atopic, Rash vesicular, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1227 | 26801276 |
US |
1 | |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, LEBRIKIZUMAB-LBKZ, ENALAPRIL MALEATE, ENALAPRIL, PRAZOSIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 1228 | 26801747 |
US |
2 | |
Hyperhidrosis, Dermatitis atopic, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, CETIRIZINE HYDROCHLORIDE, |
||||
| 1229 | 26801751 |
US |
1 | |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, CARVEDILOL, ROSUVASTATIN CALCIUM, |
||||
| 1230 | 26802129 |
US |
20 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1231 | 26802140 |
US |
51 | 2 |
Sunburn, Skin exfoliation, Eyelids pruritus, Dermatitis atopic, Erythema, Pruritus, Skin swelling, Dry skin, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, OCTOCRYLENE, AVOBENZONE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MAGNESIUM, PROGESTERONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ROFLUMILAST, CETIRIZINE HYDROCHLORIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MAGNESIUM, PROGESTERONE, CETIRIZINE HYDROCHLORIDE, ROFLUMILAST, |
||||
| 1232 | 26802423 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, Asthma, Nasal polyps, Eosinophilic oesophagitis, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, FLUTICASONE PROPIONATE, MELATONIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, |
||||
| 1233 | 26802440 |
US |
67 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DULAGLUTIDE, |
||||
| 1234 | 26802792 |
US |
1 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1235 | 26803004 |
US |
35 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1236 | 26803006 |
US |
2 | |
Dermatitis atopic, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 1237 | 26803007 |
US |
40 | 1 |
Dermatitis allergic, Dermatitis atopic, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1238 | 26803295 |
US |
29 | 1 |
Dermatitis atopic, Urticaria, Eczema, Pain, Chills, |
||||
DUPILUMAB, |
||||
| 1239 | 26803297 |
US |
61 | 2 |
Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1240 | 26803380 |
US |
25 | |
Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1241 | 26803566 |
US |
56 | 2 |
Dermatitis atopic, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1242 | 26793878 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1243 | 26793879 |
US |
2 | |
Dermatitis atopic, Pruritus, Pain, Skin fissures, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1244 | 26793890 |
US |
2 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1245 | 26793935 |
US |
||
Dermatitis atopic, |
||||
OMALIZUMAB, |
||||
| 1246 | 26794073 |
US |
63 | 2 |
Dry skin, Pruritus, Skin haemorrhage, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1247 | 26794077 |
US |
20 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1248 | 26794293 |
US |
58 | 1 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 1249 | 26794297 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1250 | 26794299 |
US |
34 | 1 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 1251 | 26794302 |
US |
45 | 1 |
Adverse event, Dermatitis atopic, |
||||
DUPILUMAB, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, |
||||
| 1252 | 26794306 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1253 | 26794504 |
US |
6 | 1 |
Dermatitis atopic, Treatment noncompliance, |
||||
DUPILUMAB, |
||||
| 1254 | 26794513 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1255 | 26794515 |
US |
30 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1256 | 26794517 |
US |
43 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1257 | 26794518 |
US |
80 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1258 | 26794532 |
US |
68 | 2 |
Rash, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1259 | 26794866 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1260 | 26794951 |
EU |
30 | 2 |
Psoriasis, Dermatitis atopic, |
||||
CYCLOSPORINE, |
||||
| 1261 | 26795191 |
US |
14 | 1 |
Dermatitis atopic, Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1262 | 26795501 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1263 | 26795521 |
US |
76 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, PREGABALIN, |
||||
| 1264 | 26795526 |
US |
24 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1265 | 26795996 |
US |
30 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1266 | 26796009 |
US |
85 | 2 |
Dementia, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1267 | 26796113 |
CN |
55 | |
Dermatitis atopic, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, CISPLATIN, CISPLATIN, |
||||
| 1268 | 26796354 |
US |
15 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1269 | 26796358 |
US |
54 | 1 |
Dermatitis atopic, Rash, Pruritus, |
||||
DUPILUMAB, |
||||
| 1270 | 26796364 |
US |
14 | 2 |
Hypersensitivity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1271 | 26796387 |
US |
2 | |
Rash, Skin irritation, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1272 | 26796389 |
US |
15 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1273 | 26796405 |
US |
9 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1274 | 26796543 |
US |
78 | |
Dermatitis atopic, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1275 | 26796666 |
US |
35 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1276 | 26796673 |
US |
39 | 2 |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 1277 | 26796705 |
US |
5 | 2 |
Eyelid exfoliation, Pyrexia, Ocular hyperaemia, Respiratory disorder, Hypersensitivity, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1278 | 26796939 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1279 | 26796964 |
US |
25 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1280 | 26796974 |
US |
5 | 1 |
Dermatitis atopic, Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 1281 | 26797213 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1282 | 26797214 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1283 | 26797386 |
US |
20 | 2 |
Dermatitis atopic, Rash, Erythema, |
||||
DUPILUMAB, |
||||
| 1284 | 26797821 |
US |
3 | 1 |
Infection, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1285 | 26797912 |
US |
19 | 1 |
Dermatitis atopic, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 1286 | 26797913 |
US |
34 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, BENZOYL PEROXIDE, FLUOCINOLONE ACETONIDE, LORATADINE, LORATADINE ORAL, MUPIROCIN, MUPIROCIN CALCIUM, WHITE PETROLATUM, BABY PETROLEUM JELLY, PETROLATUM, PETROLEUM JELLY, WHITE PETROLATUM JELLY, TRETINOIN, |
||||
| 1287 | 26797916 |
US |
39 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1288 | 26798052 |
US |
1 | |
Dermatitis atopic, Drug dose omission by device, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1289 | 26798224 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1290 | 26793020 |
US |
2 | |
Gait disturbance, Mobility decreased, Eye pain, Nasal polyps, Dermatitis atopic, Arthralgia, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1291 | 26793028 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1292 | 26793035 |
US |
60 | 2 |
Injection site pain, Pruritus, Skin burning sensation, Dry skin, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ROFLUMILAST, |
||||
| 1293 | 26793075 |
US |
76 | 1 |
Dermatitis atopic, Rash pruritic, Rash erythematous, Rash, Paranasal sinus hypersecretion, Cough, Therapeutic response decreased, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CEPHALEXIN, LORATADINE, LORATADINE TABLET, FINASTERIDE, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PRAVASTATIN SODIUM, |
||||
| 1294 | 26793092 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1295 | 26793126 |
US |
45 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1296 | 26793130 |
US |
68 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1297 | 26793140 |
US |
58 | 2 |
Peripheral swelling, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1298 | 26793144 |
US |
35 | 2 |
Dermatitis atopic, Rash, Skin discomfort, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, TIRZEPATIDE, |
||||
| 1299 | 26793169 |
US |
48 | 1 |
Dermatitis atopic, Dry skin, Skin fissures, Pruritus, Sleep disorder due to a general medical condition, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1300 | 26793170 |
US |
8 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30